Get In Touch

Mounting concerns over antibiotic resistance in humans and increasing demand for meat, milk, and eggs will continue to influence discussion on veterinary healthcare. While the US, Canada, and countries in Western Europe have some of the strongest animal healthcare standards – backed up by strong legislation – developing countries are also joining the fray with government support and legislation witnessing an uptick in recent years.

The global veterinary healthcare market is currently valued at nearly US$ 35 billion, and is expected to witness steady growth rates in the next decade. However, there are a plethora of changes currently underway in this highly lucrative market that can have an impact on the stakeholders. Among rising concerns on the effect of long-term antibiotics use, many farm- and pet-owners are making the shift to vaccines. The move is being supported by veterinary healthcare activists. In view of anticipated growth of the veterinary vaccines market, which is estimated to reach $9.5 bn by 2020, Elanco LLC (Eli Lilly & Co.) recently opened a 48,000-square-facility in Indianapolis. The facility is expected to focus on developing vaccines for farm animals, which according to estimates total 70 billion. However, antibiotics aren’t expected to disappear anytime soon, as they remain a credible method of disease prevention and management around the globe. The global veterinary antibiotics market is expected to witness moderate growth during the forecast period 2016-2024.

Impact of FDA Regulations on Animal Antibiotics Market

The U.S. Food and Drug Administration (FDA) has been working on regularizing the use of antibiotics in veterinary healthcare. From defining “medically significant” antibiotics in 2003 to setting up the Veterinary Feed Additive (VFA) rule, the FDA is keeping a strict watch on the non-prescribed use of antibiotics in animal feed. The VFD final rule, which will come into effect from January 1, 2017, makes it mandatory to present a prescription to a veterinarian for buying a feed containing a covered antibiotic. Although these regulations are anticipated to serve well in the long-term, they can stymie demand for veterinary antibiotics in the short-term.

Europe Planning to Tighten its Grip on Veterinary Antibiotics

The proposed European Union regulation that governs the use of antibiotics on animals can also have an impact on sales in Europe. The proposal focuses on collecting, compiling, and reporting antibiotic use in animal feed and for disease mitigation. Regulatory authorities in Europe have been monitoring the state of veterinary healthcare and in 2015, EFSA, ECDC, and EMA concluded, in a joint report, that certain antimicrobials were associated with resistance to these antimicrobials in humans and animals.

While demand for antibiotics in developed countries may decline in the future, manufacturers can look to consolidate their position in developing regions, where regulations on use of antibiotics aren’t as stringent as they are in the U.S. and Europe. The Asia Pacific veterinary antibiotics market is expected to grow at a higher CAGR than North America and Europe markets, owing to laxer regulations.

Commonly used antibiotics in animal healthcare include tetracyclines, penicillin, and cephalosporins. These antibiotics have remained sought-after owing to their easy availability and low cost. According to a report by FDA, sales of veterinary antibiotics in the U.S. increased by nearly 23% between 2009 and 2014. The staggering growth is another key factor that has brought the alleged antibiotic abuse into limelight in the U.S.

Veterinary Antibiotics Market: Key Players

The key players in the veterinary antibiotics market are Bayer Animal Health, Phibro Animal Health Corp.,Merial, Ceva Sante Animale S.A., Bioniche Animal Health, Fort Dodge Animal Health, Elanco Animal Health, Merck Animal Health, Virbac Animal Health, Zoetis, Inc., and Novartis Animal Health.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Veterinary Antibiotics Market

Pre Book